Cargando…
Meier-Gorlin syndrome
Meier-Gorlin syndrome (MGS) is a rare autosomal recessive primordial dwarfism disorder, characterized by microtia, patellar applasia/hypoplasia, and a proportionate short stature. Associated clinical features encompass feeding problems, congenital pulmonary emphysema, mammary hypoplasia in females a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574002/ https://www.ncbi.nlm.nih.gov/pubmed/26381604 http://dx.doi.org/10.1186/s13023-015-0322-x |
_version_ | 1782390547504168960 |
---|---|
author | de Munnik, Sonja A. Hoefsloot, Elisabeth H. Roukema, Jolt Schoots, Jeroen Knoers, Nine VAM Brunner, Han G. Jackson, Andrew P. Bongers, Ernie MHF |
author_facet | de Munnik, Sonja A. Hoefsloot, Elisabeth H. Roukema, Jolt Schoots, Jeroen Knoers, Nine VAM Brunner, Han G. Jackson, Andrew P. Bongers, Ernie MHF |
author_sort | de Munnik, Sonja A. |
collection | PubMed |
description | Meier-Gorlin syndrome (MGS) is a rare autosomal recessive primordial dwarfism disorder, characterized by microtia, patellar applasia/hypoplasia, and a proportionate short stature. Associated clinical features encompass feeding problems, congenital pulmonary emphysema, mammary hypoplasia in females and urogenital anomalies, such as cryptorchidism and hypoplastic labia minora and majora. Typical facial characteristics during childhood comprise a small mouth with full lips and micro-retrognathia. During ageing, a narrow, convex nose becomes more prominent. The diagnosis MGS should be considered in patients with at least two of the three features of the clinical triad of microtia, patellar anomalies, and pre- and postnatal growth retardation. In patients with short stature and/or microtia, the patellae should be assessed with care by ultrasonography before age 6 or radiography thereafter. Mutations in one of five genes (ORC1, ORC4, ORC6, CDT1, and CDC6) of the pre-replication complex, involved in DNA-replication, are detected in approximately 67-78 % of patients with MGS. Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly. Management should be directed towards in-depth investigation, treatment and prevention of associated problems, such as growth retardation, feeding problems, hearing loss, luxating patellae, knee pain, gonarthrosis, and possible pulmonary complications due to congenital pulmonary emphysema with or without broncho- or laryngomalacia. Growth hormone treatment is ineffective in most patients with MGS, but may be effective in patients in whom growth continues to decrease after the first year of life (usually growth velocity normalizes after the first year) and with low levels of IGF1. At present, few data is available about reproduction of females with MGS, but the risk of premature labor might be increased. Here, we propose experience-based guidelines for the regular care and treatment of MGS patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0322-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4574002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45740022015-09-19 Meier-Gorlin syndrome de Munnik, Sonja A. Hoefsloot, Elisabeth H. Roukema, Jolt Schoots, Jeroen Knoers, Nine VAM Brunner, Han G. Jackson, Andrew P. Bongers, Ernie MHF Orphanet J Rare Dis Review Meier-Gorlin syndrome (MGS) is a rare autosomal recessive primordial dwarfism disorder, characterized by microtia, patellar applasia/hypoplasia, and a proportionate short stature. Associated clinical features encompass feeding problems, congenital pulmonary emphysema, mammary hypoplasia in females and urogenital anomalies, such as cryptorchidism and hypoplastic labia minora and majora. Typical facial characteristics during childhood comprise a small mouth with full lips and micro-retrognathia. During ageing, a narrow, convex nose becomes more prominent. The diagnosis MGS should be considered in patients with at least two of the three features of the clinical triad of microtia, patellar anomalies, and pre- and postnatal growth retardation. In patients with short stature and/or microtia, the patellae should be assessed with care by ultrasonography before age 6 or radiography thereafter. Mutations in one of five genes (ORC1, ORC4, ORC6, CDT1, and CDC6) of the pre-replication complex, involved in DNA-replication, are detected in approximately 67-78 % of patients with MGS. Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly. Management should be directed towards in-depth investigation, treatment and prevention of associated problems, such as growth retardation, feeding problems, hearing loss, luxating patellae, knee pain, gonarthrosis, and possible pulmonary complications due to congenital pulmonary emphysema with or without broncho- or laryngomalacia. Growth hormone treatment is ineffective in most patients with MGS, but may be effective in patients in whom growth continues to decrease after the first year of life (usually growth velocity normalizes after the first year) and with low levels of IGF1. At present, few data is available about reproduction of females with MGS, but the risk of premature labor might be increased. Here, we propose experience-based guidelines for the regular care and treatment of MGS patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0322-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-17 /pmc/articles/PMC4574002/ /pubmed/26381604 http://dx.doi.org/10.1186/s13023-015-0322-x Text en © de Munnik et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review de Munnik, Sonja A. Hoefsloot, Elisabeth H. Roukema, Jolt Schoots, Jeroen Knoers, Nine VAM Brunner, Han G. Jackson, Andrew P. Bongers, Ernie MHF Meier-Gorlin syndrome |
title | Meier-Gorlin syndrome |
title_full | Meier-Gorlin syndrome |
title_fullStr | Meier-Gorlin syndrome |
title_full_unstemmed | Meier-Gorlin syndrome |
title_short | Meier-Gorlin syndrome |
title_sort | meier-gorlin syndrome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574002/ https://www.ncbi.nlm.nih.gov/pubmed/26381604 http://dx.doi.org/10.1186/s13023-015-0322-x |
work_keys_str_mv | AT demunniksonjaa meiergorlinsyndrome AT hoefslootelisabethh meiergorlinsyndrome AT roukemajolt meiergorlinsyndrome AT schootsjeroen meiergorlinsyndrome AT knoersninevam meiergorlinsyndrome AT brunnerhang meiergorlinsyndrome AT jacksonandrewp meiergorlinsyndrome AT bongerserniemhf meiergorlinsyndrome |